Development of an injectable sustained-release formulation of morphine: antinociceptive properties in rats.
The antinociceptive actions of morphine incorporated into an injectable chitosan-based gel were investigated in rats. Subcutaneous administration of 4.8 mg/kg morphine sulphate in a gel composed of N,O-carboxymethylchitosan (NOCC) and chitosan resulted in significant antinociception within 10 min that was maximal at 60 min and persisted for 6 h. In contrast, the same dose of morphine sulphate injected in sterile saline produced maximal responses at 30 min but only persisted for 2 h. NOCC/chitosan gel was easily injectable using a 22 guage needle and appears stable in long-term storage. No local or systemic adverse effects other than morphine-induced sedation were observed either at the time of injection or during the subsequent 48 h. We conclude that gels composed of chitosan and chitosan derivatives are effective matrices for sustained-release formulations of opioid analgesics capable of providing long-lasting antinociception.
Tasker
R A
RA
Department of Anatomy & Physiology, Atlantic Veterinary College, Charlottetown, PEI, Canada.
Connell
B J
BJ
Ross
S J
SJ
Elson
C M
CM
D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D003692:Delayed-Action Preparations; D007279:Injections, Subcutaneous; D008297:Male; D009020:Morphine / Q000008:administration & dosage* / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D051381:Rats / Q000502:physiology*; D017207:Rats, Sprague-Dawley
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D009020:Morphine